Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Endomed Oy
OY
Active
Y-tunnus 2649138-9
Hiojankuja 2A, 02780
Espoo
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2014 · 11 years old
4 employees
Share
Finland
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Endomed Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
6M
5M
3M
2M
0M
2021: 4M
4M
2021
2022: 4M (0% vs 2021)
4M
0%
2022
2023: 5M (+25% vs 2022)
5M
+25%
2023
2024: 3M (-40% vs 2023)
3M
-40%
2024
2025: 3M (0% vs 2024)
3M
0%
2025
EBITDA
EUR millions
0M
0M
0M
-1M
-1M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
Income statement
EUR thousands
Item
2025
2024
2023
2022
2021
Revenue
3 482
3 373
5 062
4 169
4 438
Staff expenses
−549
−486
−559
−555
−502
EBITDA
−363
−172
424
30
282
Depreciation & amort.
−68
−42
−72
−29
−21
EBIT
−431
−214
352
1
261
Net financials
1
7
6
−0
−0
Profit before tax
−230
−107
8
1
54
Tax
−0
0
4
0
43
Net profit
−230
−107
4
1
11
Balance sheet
EUR thousands
Item
2025
2024
2023
2022
2021
Total assets
1 140
1 551
1 894
1 913
1 891
Equity
401
631
738
734
733
Long-term debt
0
0
0
—
—
Short-term debt
739
920
1 157
1 179
1 158
Total debt
739
920
1 157
1 179
1 158
Financial ratios
5-year trend
EBITDA margin
−10,4 %
This company
15,8 %
Market median
This company
Market median
166% below market
2021
2025
Equity ratio
35,2 %
This company
38,2 %
Market median
This company
Market median
8% below market
2021
2025
Return on equity
−57,3 %
This company
18,4 %
Market median
This company
Market median
411% below market
2021
2025
Net profit margin
−6,6 %
This company
8,1 %
Market median
This company
Market median
181% below market
2021
2025
Asset turnover
3,06×
This company
1,12×
Market median
This company
Market median
173% above market
2021
2025
Debt / equity
1,84×
This company
0,62×
Market median
This company
Market median
197% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
View
PDF
More on Endomed Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
